FI944961L - Farmaseuttinen valmiste ja menetelmä sen valmistamiseksi - Google Patents

Farmaseuttinen valmiste ja menetelmä sen valmistamiseksi Download PDF

Info

Publication number: FI944961L
Authority: FI; Finland
Prior art keywords: preparation; pharmaceutical; pharmaceutical preparation
Prior art date: 1992-04-24

Application number

FI944961A

Other languages

English (en)

Swedish (sv)

Other versions

FI110667B (fi

FI944961A0 (fi

Inventor

Juhani Posti

Kirsi Katila

Pertti Rantala

Original Assignee

Leiras Oy

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-04-24

Filing date

1994-10-21

Publication date

1994-10-21

1994-10-21 Application filed by Leiras Oy filed Critical Leiras Oy

1994-10-21 Priority to FI944961A priority Critical patent/FI110667B/fi

1994-10-21 Publication of FI944961L publication Critical patent/FI944961L/fi

1994-10-21 Publication of FI944961A0 publication Critical patent/FI944961A0/fi

2003-03-14 Application granted granted Critical

2003-03-14 Publication of FI110667B publication Critical patent/FI110667B/fi

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Physical Education & Sports Medicine (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Orthopedic Medicine & Surgery (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Rheumatology (AREA)
Chemical Kinetics & Catalysis (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)

FI944961A 1992-04-24 1994-10-21 Menetelmä farmaseuttisen valmisteen valmistamiseksi FI110667B (fi)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
FI944961A FI110667B (fi)	1992-04-24	1994-10-21	Menetelmä farmaseuttisen valmisteen valmistamiseksi

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
SE9201299A SE501389C2 (sv)	1992-04-24	1992-04-24	Farmaceutiskt preparat och förfarande för dess framställning
PCT/FI1993/000166 WO1993021907A1 (en)	1992-04-24	1993-04-21	Pharmaceutical preparation and process for its manufacture
FI944961A FI110667B (fi)	1992-04-24	1994-10-21	Menetelmä farmaseuttisen valmisteen valmistamiseksi

Publications (3)

Publication Number	Publication Date
FI944961L true FI944961L (fi)	1994-10-21
FI944961A0 FI944961A0 (fi)	1994-10-21
FI110667B FI110667B (fi)	2003-03-14

Family

ID=20386054

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI944961A FI110667B (fi)	1992-04-24	1994-10-21	Menetelmä farmaseuttisen valmisteen valmistamiseksi

Country Status (21)

Country	Link
US (1)	US5525354A (fi)
EP (1)	EP0637236B1 (fi)
JP (1)	JP3536106B2 (fi)
AT (1)	ATE143802T1 (fi)
AU (1)	AU671830B2 (fi)
CA (1)	CA2134196C (fi)
CZ (1)	CZ282871B6 (fi)
DE (2)	DE69305335T2 (fi)
DK (1)	DK0637236T3 (fi)
EE (1)	EE03107B1 (fi)
ES (1)	ES2094539T3 (fi)
FI (1)	FI110667B (fi)
GR (1)	GR3022249T3 (fi)
HK (1)	HK13097A (fi)
HU (1)	HU219342B (fi)
IL (1)	IL105403A (fi)
NO (1)	NO306654B1 (fi)
RU (1)	RU2116074C1 (fi)
SE (1)	SE501389C2 (fi)
TW (1)	TW273515B (fi)
WO (1)	WO1993021907A1 (fi)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6406714B1 (en)	1992-12-02	2002-06-18	Merck & Co., Inc.	Dry mix formulation for bisphosphonic acids
ES2065313T5 (es) *	1993-05-15	2004-01-01	Roche Diagnostics Gmbh	Tableta con biodisponibilidad mejorada que contiene acido diclorometilendifosfonico como sustancia activa.
US5431920A (en) *	1993-09-21	1995-07-11	Merck Frosst, Canada, Inc.	Enteric coated oral compositions containing bisphosphonic acid antihypercalcemic agents
FI94926C (fi) *	1993-11-12	1995-11-27	Leiras Oy	Menetelmä klodronaattivalmisteen valmistamiseksi
US20010007863A1 (en)	1998-06-18	2001-07-12	Merck & Co., Inc.	Wet granulation formulation for bisphosphonic acids
TW390813B (en) *	1994-04-29	2000-05-21	Merck & Co Inc	Wet granulation formulation for bisphosphonic acids
FI98343C (fi) *	1995-03-21	1997-06-10	Orion Yhtymae Oy	Peroraalinen formulaatio
DE19719680A1 (de)	1997-05-09	1998-11-19	Boehringer Mannheim Gmbh	Verwendung von Diphosphonsäuren zur präventiven Behandlung von Spätfolgen bei Harnblasenerweiterung oder Harnblasenersatz
JPH11137208A (ja) *	1997-11-14	1999-05-25	Nikken Chem Co Ltd	口腔内速溶性固形物及びその製造方法
EP0998932A1 (de) *	1998-10-09	2000-05-10	Boehringer Mannheim Gmbh	Feste pharmazeutische Darreichungsform enthaltend Diphosphonsäure oder deren Salze und Verfahren zu ihrer Herstellung
EP0998933A1 (de) *	1998-10-09	2000-05-10	Boehringer Mannheim Gmbh	Verfahren zur Herstellung von bisphosphonathaltigen pharmazeutischen Zusammensetzungen zur oralen Applikation
ES2301477T3 (es) *	1999-02-22	2008-07-01	Merrion Research I Limited	Forma de dosificacion oral solida que contiene un potenciador.
US7658938B2 (en)	1999-02-22	2010-02-09	Merrion Reasearch III Limited	Solid oral dosage form containing an enhancer
SE9901272D0 (sv) *	1999-04-09	1999-04-09	Astra Ab	New improved formulation
PE20011061A1 (es)	2000-02-01	2001-11-20	Procter & Gamble	Cristalizacion selectiva del acido 3-piridil-1-hidroxi-etiliden-1,1-bisfosfonico sodio como el hemipentahidrato o el monohidrato
PE20011065A1 (es)	2000-02-01	2001-11-21	Procter & Gamble	Proceso para fabricar bisfosfonatos geminales
CA2446619C (en)	2001-05-11	2011-04-26	Elan Corporation, Plc	Permeation enhancers
US20030070584A1 (en) *	2001-05-15	2003-04-17	Cynthia Gulian	Dip coating compositions containing cellulose ethers
AU4061702A (en) *	2001-05-15	2003-04-03	Mcneil-Ppc, Inc.	Dip coating compositions containing starch or dextrin
US8309118B2 (en) *	2001-09-28	2012-11-13	Mcneil-Ppc, Inc.	Film forming compositions containing sucralose
US7429619B2 (en) *	2002-08-02	2008-09-30	Mcneil Consumer Healthcare	Polyacrylic film forming compositions
US20080286359A1 (en)	2004-05-24	2008-11-20	Richard John Dansereau	Low Dosage Forms Of Risedronate Or Its Salts
US7645459B2 (en)	2004-05-24	2010-01-12	The Procter & Gamble Company	Dosage forms of bisphosphonates
US20080287400A1 (en)	2004-05-24	2008-11-20	Richard John Dansereau	Low Dosage Forms Of Risedronate Or Its Salts
US7645460B2 (en)	2004-05-24	2010-01-12	The Procter & Gamble Company	Dosage forms of risedronate
US7862552B2 (en) *	2005-05-09	2011-01-04	Boston Scientific Scimed, Inc.	Medical devices for treating urological and uterine conditions
KR101191322B1 (ko)	2006-04-07	2012-10-16	메리온 리서치 Ⅲ 리미티드	증진제를 함유하는 고형 경구용 투여 제형
CA2723558A1 (en)	2008-05-07	2009-11-12	Merrion Research Iii Limited	Compositions of gnrh related compounds and processes of preparation
DE102008022520A1 (de) *	2008-05-07	2009-11-12	Bayer Animal Health Gmbh	Feste Arzneimittelformulierung mit verzögerter Freisetzung
US9089484B2 (en)	2010-03-26	2015-07-28	Merrion Research Iii Limited	Pharmaceutical compositions of selective factor Xa inhibitors for oral administration
US8802114B2 (en)	2011-01-07	2014-08-12	Merrion Research Iii Limited	Pharmaceutical compositions of iron for oral administration
WO2016120378A1 (en)	2015-01-29	2016-08-04	Novo Nordisk A/S	Tablets comprising glp-1 agonist and enteric coating

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS57171428A (en) *	1981-04-13	1982-10-22	Sankyo Co Ltd	Preparation of coated solid preparation
DE3767998D1 (de) *	1986-12-20	1991-03-14	Boehringer Mannheim Gmbh	Clodronat-haltige arzneimittel und verfahren zur herstellung derselben.
JP2782691B2 (ja) *	1987-09-29	1998-08-06	ワーナー−ランバート・コンパニー	腸溶製剤の安定化
FR2629716B1 (fr) *	1988-04-07	1991-07-19	Sanofi Sa	Composition pharmaceutique pour administration orale a base d'un derive d'acide diphosphonique

1992
- 1992-04-24 SE SE9201299A patent/SE501389C2/sv not_active IP Right Cessation
1993
- 1993-04-13 TW TW082102782A patent/TW273515B/zh active
- 1993-04-15 IL IL105403A patent/IL105403A/en not_active IP Right Cessation
- 1993-04-21 DE DE69305335T patent/DE69305335T2/de not_active Expired - Fee Related
- 1993-04-21 HU HU9403067A patent/HU219342B/hu not_active IP Right Cessation
- 1993-04-21 CA CA002134196A patent/CA2134196C/en not_active Expired - Fee Related
- 1993-04-21 RU RU94045950A patent/RU2116074C1/ru not_active IP Right Cessation
- 1993-04-21 DK DK93908973.6T patent/DK0637236T3/da active
- 1993-04-21 AT AT93908973T patent/ATE143802T1/de not_active IP Right Cessation
- 1993-04-21 CZ CZ942614A patent/CZ282871B6/cs not_active IP Right Cessation
- 1993-04-21 ES ES93908973T patent/ES2094539T3/es not_active Expired - Lifetime
- 1993-04-21 US US08/318,650 patent/US5525354A/en not_active Expired - Lifetime
- 1993-04-21 DE DE0637236T patent/DE637236T1/de active Pending
- 1993-04-21 JP JP51895893A patent/JP3536106B2/ja not_active Expired - Fee Related
- 1993-04-21 WO PCT/FI1993/000166 patent/WO1993021907A1/en active IP Right Grant
- 1993-04-21 AU AU39550/93A patent/AU671830B2/en not_active Ceased
- 1993-04-21 EP EP93908973A patent/EP0637236B1/en not_active Expired - Lifetime
1994
- 1994-10-21 NO NO944001A patent/NO306654B1/no unknown
- 1994-10-21 FI FI944961A patent/FI110667B/fi active
- 1994-11-15 EE EE9400134A patent/EE03107B1/xx not_active IP Right Cessation
1997
- 1997-01-09 GR GR970400013T patent/GR3022249T3/el unknown
- 1997-02-05 HK HK13097A patent/HK13097A/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
EP0637236A1 (en)	1995-02-08
US5525354A (en)	1996-06-11
CZ282871B6 (cs)	1997-11-12
HK13097A (en)	1997-02-14
DE69305335D1 (de)	1996-11-14
NO944001D0 (no)	1994-10-21
IL105403A (en)	1998-03-10
TW273515B (fi)	1996-04-01
GR3022249T3 (en)	1997-04-30
DK0637236T3 (da)	1997-03-17
CZ261494A3 (en)	1995-02-15
FI110667B (fi)	2003-03-14
ATE143802T1 (de)	1996-10-15
ES2094539T3 (es)	1997-01-16
IL105403A0 (en)	1993-08-18
DE637236T1 (de)	1995-07-06
NO944001L (no)	1994-10-21
SE501389C2 (sv)	1995-01-30
EP0637236B1 (en)	1996-10-09
SE9201299L (sv)	1993-10-25
WO1993021907A1 (en)	1993-11-11
HU9403067D0 (en)	1994-12-28
JPH07505898A (ja)	1995-06-29
FI944961A0 (fi)	1994-10-21
RU2116074C1 (ru)	1998-07-27
JP3536106B2 (ja)	2004-06-07
AU671830B2 (en)	1996-09-12
CA2134196A1 (en)	1993-11-11
HU219342B (en)	2001-03-28
SE9201299D0 (sv)	1992-04-24
EE03107B1 (et)	1998-08-17
NO306654B1 (no)	1999-12-06
DE69305335T2 (de)	1997-04-30
CA2134196C (en)	2004-02-10
HUT74572A (en)	1997-01-28
AU3955093A (en)	1993-11-29
RU94045950A (ru)	1996-11-10

Publication	Publication Date	Title
FI944961L (fi)	1994-10-21	Farmaseuttinen valmiste ja menetelmä sen valmistamiseksi
FI964028L (fi)	1996-10-08	Uusi farmaseuttinen formulaatio ja menetelmä
FI951305L (fi)	1995-03-20	Lääketieteellinen materiaali ja menetelmä sen valmistamiseksi
FI941137L (fi)	1994-09-12	2-debentsoyyli-2-asyylitaksolijohdannaisia ja menetelmiä niiden valmistamiseksi
FI935665L (fi)	1994-06-29	Maitotuote ja menetelmä sen valmistamiseksi
FI940585L (fi)	1994-08-11	Pinnoittamattomat tabletit ja menetelmä niiden valmistamiseksi
FI945198L (fi)	1994-11-04	Farmaseuttiset ja muut annosmuodot
FI956270L (fi)	1995-12-27	Piperdiinijohdannaisia ja menetelmä niiden valmistamiseksi
FI944452L (fi)	1995-03-29	Gelatiinikapseli ja menetelmä sen valmistamiseksi
CY2003003I1 (el)	2010-07-28	Παραγωγα πυριμιδινης και μεθοδος για την παρασκευη τους
FI944279L (fi)	1994-09-15	Suolatuote ja menetelmä sen valmistamiseksi
BR1100824A (pt)	1999-08-31	Composto e composição farmacêutica
FI946104L (fi)	1995-06-29	Erittäin konsentroitu immunoglobuliinivalmiste ja menetelmä sen valmistamiseksi
FI961221L (fi)	1996-05-14	Uusi menetelmä progesteronin antamiseksi ja sen vaikutus
FI953904L (fi)	1995-10-18	Varmuusdokumentti ja menetelmä sen valmistamiseksi
FI942745L (fi)	1994-12-12	Fluoreeniyhdisteitä ja valmistusmenetelmä
FI955362A0 (fi)	1995-11-08	Symmetrointilaite ja menetelmä sen suunnittelemiseksi
FI953479A0 (fi)	1995-07-18	1-aryylipyrimidiinijohdannaiset ja niiden farmaseuttinen käyttö
FI962445L (fi)	1996-06-12	Paroksetiinitabletteja ja menetelmä niiden valmistamiseksi
FI943316L (fi)	1994-07-12	Farmaseuttiset koostumukset, joissa on nifedipiiniä ja menetelmä sen valmistamiseksi
FI930882A0 (fi)	1993-02-26	Farmaceutiska foereningar
FI935465L (fi)	1994-06-08	Termoplastinen koostumus, menetelmä sen valmistamiseksi ja sen käyttö
FI943383L (fi)	1994-08-31	Yhdiste FO-1289 ja menetelmä sen valmistamiseksi
FI956080L (fi)	1996-01-17	Kuidutettu selluloosatuote ja menetelmä sen valmistamiseksi
FI943207L (fi)	1994-07-05	4,5-dihydrogeldanamysiinin ja sen hydrokinonin valmistusmenetelmä ja käyttö